A nation-wide effort first launched in New Hampshire in 2009 is enlisting gun retailers in the fight against suicide. Researchers at CU Boulder want to learn how it's working and what can be done to make it work even better.
In the years after female faculty members have children, their productivity––in terms of papers published––drops 20 percent. Male faculty see no such decline. Researchers say different roles in parenting are likely to blame and the gap could have long-term impacts on higher education.
As supply increases, so do questions about how the COVID-19 vaccines work and what they do and don’t do. We caught up with Professor Matt McQueen, director of epidemiology, for answers.
Facial recognition technology is now embedded in everything from our phones and computers to surveillance systems at the mall and airport. But it tends to misidentify certain populations and can be used to discriminate. Microsoft Research Fellow Morgan Klaus Scheuerman wants to change that.
New research suggests drugs called PARP inhibitors, designed to treat breast and ovarian cancers, work differently than previously presumed. It also shines a light on how they do work, opening the door for improved next-generation drugs.
As leaders face tough decisions about who to vaccinate against COVID-19, a new study finds that vaccinating adults 60 or older first will save the most lives in the long term.
CU Boulder researchers have discovered a new compound capable of pushing past the defenses of antibiotic-resistant bacteria. It, and other recent discoveries from the lab, could lead to a new arsenal for combating the rising threat of superbugs.
A new neuroimaging study offers a first look at what happens in the brain when we try to stop thinking about one thing in order to make room for new ideas. The findings offer clues on how to be more productive when studying and working. They could also lead to new therapies for trauma and anxiety disorders.
